A study to assess the safety and tolerability of single doses of AZD4076 in healthy male subjects

Trial Identifier:	D5590C00001
Sponsor:	AstraZeneca
NCTID::	NCT02612662
Start Date:	November 2015
Primary Completion Date:	November 2017
Study Completion Date:	August 2024
Condition:	Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, MD	Brooklyn, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.